
### [NCIT:C7047](http://purl.obolibrary.org/obo/NCIT_C7047)
**Label:** Functioning Pituitary Gland Neoplasm

**Subclasses:** [NCIT:C121720](http://purl.obolibrary.org/obo/NCIT_C121720) (Functioning Pituitary Gland Macroadenoma), [NCIT:C8388](http://purl.obolibrary.org/obo/NCIT_C8388) (Functioning Pituitary Gland Adenoma), [NCIT:C121679](http://purl.obolibrary.org/obo/NCIT_C121679) (Functioning Pituitary Gland Microadenoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C32044](http://purl.obolibrary.org/obo/NCIT_C32044) (Acidophilic Cell))) 53.12%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37872](http://purl.obolibrary.org/obo/NCIT_C37872) (Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37870](http://purl.obolibrary.org/obo/NCIT_C37870) (Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37867](http://purl.obolibrary.org/obo/NCIT_C37867) (Tetrasomy 7))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37866](http://purl.obolibrary.org/obo/NCIT_C37866) (Trisomy 16))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37865](http://purl.obolibrary.org/obo/NCIT_C37865) (Trisomy 17))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3756](http://purl.obolibrary.org/obo/NCIT_C3756) (Mixed Embryonal Carcinoma and Teratoma))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3742](http://purl.obolibrary.org/obo/NCIT_C3742) (Myofibromatosis))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3741](http://purl.obolibrary.org/obo/NCIT_C3741) (Abdominal (Mesenteric) Fibromatosis))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3740](http://purl.obolibrary.org/obo/NCIT_C3740) (Bone Desmoplastic Fibroma))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3736](http://purl.obolibrary.org/obo/NCIT_C3736) (Adrenal Gland Myelolipoma))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37312](http://purl.obolibrary.org/obo/NCIT_C37312) (Loss of Chromosome 11q))) 38.48%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C37304](http://purl.obolibrary.org/obo/NCIT_C37304) (Multicentric Thyroid Gland Papillary Carcinoma))) 38.48%


